ad

Metropolis Healthcare Q2 Results FY27: PAT Jumps 42.71% to Rs 75.48 Cr, Revenue Rs 496.82 Cr

4 Nov 2026 • 2:22 pm

Metropolis Healthcare Q2 Results FY27: PAT Jumps 42.71% to Rs 75.48 Cr, Revenue Rs 496.82 Cr

Quick Answer

Metropolis Healthcare Q2 Results FY27 were declared on 3 November 2026. The company reported consolidated revenue of Rs 496.82 Cr, up 15.76% YoY from Rs 429.19 Cr, while net profit rose 42.71% YoY to Rs 75.48 Cr from Rs 52.89 Cr. These quarterly results show YoY growth in both revenue and net profit.

Metropolis Healthcare Ltd (METROPOLIS) Q2 Results FY27 announced on 3 November 2026, covering the company's financial performance for the July to September quarter. The results date brought consolidated revenue of Rs 496.82 Cr and PAT of Rs 75.48 Cr into view. Metropolis Healthcare Q2 Results FY27 therefore record revenue growth of 15.76% over the same quarter last year, and the consolidated results also show higher profit.

This Metropolis Healthcare Q2 Results results analysis covers the financial highlights, the business factors named in the disclosure, the outlook for FY27 and the risks to watch. Listed on NSE and BSE under the symbol METROPOLIS, the company reports on a consolidated basis, so each figure below reflects the group. The Financial Highlights come next.

Click Here – Get Free Investment Predictions

Metropolis Healthcare Q2 Results FY27: Financial Highlights

Metric Q2 FY27 (Sep 26) Q2 FY26 (Sep 25) YoY Change
Revenue Rs 496.82 Cr Rs 429.19 Cr +15.76% YoY
Operating Profit Rs 134.02 Cr Rs 108.22 Cr +23.84% YoY
Net Profit (PAT) Rs 75.48 Cr Rs 52.89 Cr +42.71% YoY

Source: company filing for Metropolis Healthcare Q2 Results FY27, 3 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Metropolis Healthcare Q2 Results: What Stands Out

  • Revenue of Rs 496.82 Cr compares with Rs 429.19 Cr in the same quarter last year, a YoY growth of 15.76% on a consolidated basis.
  • Net profit of Rs 75.48 Cr compares with Rs 52.89 Cr a year earlier, an increase of 42.71% YoY, which is much faster than the revenue growth.
  • Operating Profit stood at Rs 134.02 Cr versus Rs 108.22 Cr in the year-ago quarter, a rise of 23.84% YoY.
  • Net profit margin improved to 15.2% from 12.3% in the comparison quarter, as supplied for Metropolis Healthcare Q2 Results FY27.
  • Return on capital employed was 20.03% in FY26, an annual figure that leads into the performance analysis.

Metropolis Healthcare Q2 Results FY27: Performance Analysis

Consolidated revenue grew by Rs 67.63 Cr to Rs 496.82 Cr, and net profit rose by Rs 22.59 Cr to Rs 75.48 Cr from Rs 52.89 Cr. Both lines rose YoY, with net profit growing much faster than revenue, which is the main feature of these numbers.

In the Metropolis Healthcare Q2 Results FY27 results analysis, Operating Profit moved from Rs 108.22 Cr to Rs 134.02 Cr, a 23.84% YoY gain, which is faster than the 15.76% revenue growth. Net profit rose 42.71%, faster still, so profit grew more quickly than the top line.

Investors tracking this quarter will look at whether revenue growth of 15.76% carries into later filings. The quarterly results for Metropolis Healthcare also show a net profit margin of 15.2% against 12.3% in the comparison quarter, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue growth – The results analysis points to revenue first, which grew 15.8% year on year to Rs 496.82 Cr in the latest quarter. This sits against Rs 429.19 Cr in the year-ago period and forms the top line behind Metropolis Healthcare Q2 Results FY27.

Net profit rise – Net profit rose 42.7% year on year to Rs 75.48 Cr. The quarterly results show this increase against Rs 52.89 Cr a year earlier, so profit grew alongside revenue and at a much faster pace in the same period.

Margin improvement – Net profit margin improved to 15.2% from 12.3% in the comparison quarter. A higher margin means each rupee of revenue converted to more profit than a year earlier, which explains why profit outpaced sales.

FY27 Outlook After Metropolis Healthcare Q2 Results

No management guidance accompanies these figures, so the FY27 full-year picture will depend on the quarters that follow and on the sector conditions disclosed later. The Metropolis Healthcare Q2 Results FY27 results analysis offers a starting point: revenue of Rs 496.82 Cr and net profit of Rs 75.48 Cr set the reference for upcoming filings.

What matters next is whether revenue growth stays near the 15.76% YoY level and whether net profit holds above the Rs 52.89 Cr of a year ago. Those two lines will frame the full-year results for FY27, and the risks that could affect them are covered next.

Key Risks to Watch After Metropolis Healthcare Q2 Results FY27

Return on Equity Below 15%

Return on equity of 13.53% in FY26 is below 15%. This is an annual figure, and it shows a moderate return on shareholder funds, so the YoY growth in net profit will need to be read against it.

Margin Gains Need to Hold

Net profit margin improved to 15.2% from 12.3%. The profit gain leans on this wider margin, and later filings will show whether the margin holds near the current level or slips back.

Profit Growth Ahead of Sales

Net profit rose 42.71% YoY while revenue rose 15.76%. A gap this wide means the profit increase rests more on margin than on sales volume, and later filings will show whether the gap persists.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

The quarterly results show revenue of Rs 496.82 Cr, up 15.76% YoY, and net profit of Rs 75.48 Cr, up 42.71%. Taken together, Metropolis Healthcare Q2 Results FY27 describe higher revenue and profit on a consolidated basis. Investors should consult a SEBI-registered advisor before acting on any of this information.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on Metropolis Healthcare Q2 Results FY27

What are Metropolis Healthcare Q2 Results FY27?

Ans. Metropolis Healthcare Q2 Results FY27 are the consolidated quarterly results for July to September 2026, showing revenue of Rs 496.82 Cr and net profit of Rs 75.48 Cr, as covered in the Quick Answer.

What is the results date for Metropolis Healthcare Q2 Results FY27?

Ans. The results date for Metropolis Healthcare Q2 Results FY27 is 3 November 2026, when Metropolis Healthcare declared its consolidated numbers, so the Financial Highlights section reflects figures from that filing for the quarter.

What revenue was reported in Metropolis Healthcare Q2 Results FY27?

Ans. Metropolis Healthcare reported consolidated revenue of Rs 496.82 Cr in Metropolis Healthcare Q2 Results FY27, compared with Rs 429.19 Cr a year earlier, so revenue is the line to read first in the Financial Highlights.

What net profit was reported in Metropolis Healthcare Q2 Results FY27?

Ans. Net profit in Metropolis Healthcare Q2 Results FY27 was Rs 75.48 Cr, compared with Rs 52.89 Cr in the year-ago quarter, which means profit rose YoY, as the Performance Analysis section explains.

How much YoY growth did revenue show in Metropolis Healthcare Q2 Results FY27?

Ans. Revenue in Metropolis Healthcare Q2 Results FY27 grew 15.76% YoY, moving from Rs 429.19 Cr to Rs 496.82 Cr, while net profit rose 42.71%, a comparison drawn in the Key Takeaways.

Did net profit rise or fall in Metropolis Healthcare Q2 Results?

Ans. In Metropolis Healthcare Q2 Results net profit rose, from Rs 52.89 Cr to Rs 75.48 Cr, so profit is higher YoY by 42.71%, as the Key Takeaways section notes.

What was the Operating Profit in Metropolis Healthcare Q2 Results FY27?

Ans. Operating Profit in Metropolis Healthcare Q2 Results FY27 was Rs 134.02 Cr compared with Rs 108.22 Cr a year earlier, a 23.84% YoY rise, which is detailed in the Performance Analysis.

Are Metropolis Healthcare Q2 Results consolidated results or standalone results?

Ans. The figures in Metropolis Healthcare Q2 Results are consolidated results, covering the group, which means the revenue of Rs 496.82 Cr should be read on that basis in the Financial Highlights.

What business factors shaped Metropolis Healthcare Q2 Results FY27?

Ans. The factors listed for Metropolis Healthcare Q2 Results FY27 are revenue growth of 15.8% YoY, a net profit rise of 42.7% and a net profit margin improving to 15.2%, which the Key Business Factors section sets out.

What are the key risks after Metropolis Healthcare Q2 Results FY27?

Ans. After Metropolis Healthcare Q2 Results FY27 the risks named are return on equity of 13.53%, the need for margin gains to hold and profit growth running ahead of sales growth, all in the Key Risks section.

What is the outlook after Metropolis Healthcare Q2 Results?

Ans. No management guidance is attached to Metropolis Healthcare Q2 Results, so the FY27 outlook rests on later quarters, while the Outlook section tracks revenue and net profit as the reference points.

Where can I find the complete Metropolis Healthcare Q2 Results FY27 data?

Ans. The complete Metropolis Healthcare Q2 Results FY27 data sits in the Financial Highlights table above, which sets out revenue, Operating Profit and net profit YoY, while the Univest app and Screener carry further company details.


Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down